Lu Kang Pharmaceutical (600789.SH) has obtained the approval from the China Securities Regulatory Commission for its application to issue shares to specific investors.

The Zhitong Financial APP News, Lu Kang Pharmaceutical (600789.SH) announced that the company recently received the approval from the China Securities Regulatory Commission ("CSRC") for the issuance of stocks to specific investors, as stated in the "Approval for Shandong Lu Kang Pharmaceutical Co., Ltd. to issue stocks to specific investors" (Securities Regulatory Approval [2025] 2158). The company has been granted permission to proceed with the registration of the issuance of stocks to specific investors.